July 05, 2024
Article
Under her exceptional leadership in oncology navigation, the impact on patient outcomes has been nothing short of transformative.
Insights Into What’s New in Blood Cancer Care
Epkinly Plus Chemo Elicits Durable Responses in DLBCL
Zervyteg Shows Strong Responses in Acute Graft-Versus-Host Disease
Updated Data Reinforce Treatment With Jaypirca in CLL/SLL